Oncolytics Biotech Inc. - Common Shares (NQ:ONCY)
1.060
+0.225
(+26.99%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 13, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 4,769,753 |
| Open | 0.8900 |
| Bid (Size) | 1.140 (4,700) |
| Ask (Size) | 1.150 (4,000) |
| Prev. Close | 0.8347 |
| Today's Range | 0.8347 - 1.100 |
| 52wk Range | 0.3258 - 1.510 |
| Shares Outstanding | 46,166,980 |
| Dividend Yield | N/A |
Top News
More News
ONCY Stock Rallies On Second Fast Track Designation For Experimental Cancer Drug ↗
February 04, 2026
Via Stocktwits
Performance
| YTD |
+7.8%
|
+7.8%
|
| 1 Month |
+1.0%
|
+1.0%
|
| 3 Month |
+1.9%
|
+1.9%
|
| 6 Month |
-1.9%
|
-1.9%
|
| 1 Year |
+37.3%
|
+37.3%
|
More News
Read More
THE RESILIENCE DOCTRINE: 5 Assets Securing the 2026 Sovereign Stack
January 26, 2026
From Equity Insider
Via GlobeNewswire
Top movers in Tuesday's after hours session ↗
January 20, 2026
Via Chartmill
THE SOVEREIGN MANDATE: 5 Stocks Securing the 2026 Choke Points
January 14, 2026
From USA News Group
Via GlobeNewswire
From Equity Insider
Via GlobeNewswire
From Equity Insider
Via GlobeNewswire
THE CHOKE POINT: 5 Assets That Control the Bottleneck
January 07, 2026
From Equity Insider
Via GlobeNewswire
Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards
December 16, 2025
From Equity Insider
Via GlobeNewswire
THE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis
December 15, 2025
From USA News Group
Via GlobeNewswire
GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era
December 12, 2025
From Equity Insider
Via GlobeNewswire
THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality
December 06, 2025
From USA News Group
Via GlobeNewswire
From USA News Group
Via GlobeNewswire
The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality
December 03, 2025
From USA News Group
Via GlobeNewswire
Oncolytics Biotech® Provides Update on Special Meeting of Shareholders
November 20, 2025
Via Business Wire
From FN Media Group LLC
Via GlobeNewswire
Frequently Asked Questions
Is Oncolytics Biotech Inc. - Common Shares publicly traded?
Yes, Oncolytics Biotech Inc. - Common Shares is publicly traded.
What exchange does Oncolytics Biotech Inc. - Common Shares trade on?
Oncolytics Biotech Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Oncolytics Biotech Inc. - Common Shares?
The ticker symbol for Oncolytics Biotech Inc. - Common Shares is ONCY on the Nasdaq Stock Market
What is the current price of Oncolytics Biotech Inc. - Common Shares?
The current price of Oncolytics Biotech Inc. - Common Shares is 1.060
When was Oncolytics Biotech Inc. - Common Shares last traded?
The last trade of Oncolytics Biotech Inc. - Common Shares was at 02/13/26 04:00 PM ET
What is the market capitalization of Oncolytics Biotech Inc. - Common Shares?
The market capitalization of Oncolytics Biotech Inc. - Common Shares is 48.94M
How many shares of Oncolytics Biotech Inc. - Common Shares are outstanding?
Oncolytics Biotech Inc. - Common Shares has 49M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>